Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Chapt 17 CNS Drugs
| The ability to increase the action of the neurotransmitter GABA | Benzodiazepine | Antianxiety agent |
| Uses: Generalized Anxiety Disorder (GAD) | Benzodiazepine | Antianxiety agent |
| Uses: Panic disorders, Insomnia | Benzodiazepine | Antianxiety agent |
| Uses: In seizures injectable form of diazepam (Valium) and Lorazepam (Ativan) are commonly used to stop seizures | Benzodiazepine | Antianxiety agent |
| Uses: Long lasting drug such as phenytonin (Dilantin) are given to prevent reoccurrence of seizures | Benzodiazepine | Antianxiety agent |
| Adverse effects: Drowsiness, ataxia (inability to coordinate muscle activity); impaired judgement; rebound insomnia; development of tolerance; gradual withdrawal | Benzodiazepine | Antianxiety agent |
| Contraindications: Do not take during pregnancy, likely to cause fetal abnormalities | Benzodiazepine | Antianxiety agent |
| Contraindications: Severe liver and kidney disorders | Benzodiazepine | Antianxiety agent |
| Contraindications: Children who are hyperactive | Benzodiazepine | Antianxiety agent |
| Patient information: Use relaxation method to decrease anxiety | Benzodiazepine | Antianxiety agent |
| Patient information: Do not stop medication abruptly; do not drink alcohol or take CNS depressants while taking hypnotic or anxiolytics (sedatives) | Benzodiazepine | Antianxiety agent |
| Patient information: Avoid caffeine; do not drive or operate heavy machinery | Benzodiazepine | Antianxiety agent |
| Patient information: Elderly patients require lower dosage of diazepam to decrease ataxia and avoid oversedation | Benzodiazepine | Antianxiety agent |
| Valium (diazepam) | Benzodiazepine | Antianxiety agent |
| Ativan (lorazepam) | Benzodiazepine | Antianxiety agent |
| Relatively newer antidepressants | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Considered the first-line drugs in treatment of patients with major depression | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Primarily block the effect of serotonin uptake | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Comparable efficacy to TCAs, however TCAs are more effective with severe depression | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Uses: Depression, geriatric depression, obsessive-compulsive disorder, bulimia nervosa, premenstrual dysphoric disorder | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Adverse effects: Relatively mild, shorter duration than TCA | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Adverse effects: Caridac toxicity and risk of death after overdose are less likely than w/TCA | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Common Adverse effects: headache, nausea, vomiting tremor, insomnia, dizziness, diarrhea | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Contraindications: Hypersensitivity to the drug, | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Contraindications: should not use concurrently w/ MAOIs or thioridazine (Mellaril) | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Contraindications: Should not use during pregnancy; should not use in children under 7 yrs | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Contraindicaitons: Use with caution in patients with hepatic or renal impairment, renal failure, lactation, cardia disease, diabetes mellitus | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Patient information: Report withdrawal symptoms (abd. pain, diarrhea, nausea, headache, sweating, insomnia) | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Patient information: Report if better, worst or no change | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Patient information: Weight changes, suicidal alert, take with food, careful while driving and operating heavy machinery, avoid alcohol, take in morning to minimize insomnia | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Zoloft (sertraline) | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Luvox (fluvoxamine) | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Prozac (fluoxetine) | SSRIs (Selective Serotonin Reuptake Inhibitors) | Antidepressant agent |
| Three-ring (tricyclic) structure | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Raise the levels of norepinephrine and serotonin | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Uses: More likely to relieve endogenous depression (a chemical disorder in the brain) | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Trofanil (imipramine) | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Pamelor (nortriptyline) | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Elavil (amitriptyline) | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Adverse Effects: Anticholinergic and alpa adrenergic blocking activities | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Adverse effect: Orthostatic hypotension | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Contraindications: Avoid during acute recovery period after a heart attack; avoid in pts w/severe renal or hepatic impairment | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Contraindications: MAOIs may precipitate hyperpyrexic crisis, tachycardia or seizures | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Patient info: do not stop abruptly, take at bedtime to promote normal sleep pattern | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Patient info: Effectiveness begins after 2 wks of use | TCAs (Tricyclic Antidepressant) | Antidepressant agent |
| Block breakdown of norepinephrine and serotonin | MAOIs (Monoamine Oxidase Inhibitors) | Antidepressant agent |
| Second-third line antidepressants because of the numerous interactions w/prescriptions and OTC meds, as well as food and beverages | MAOIs (Monoamine Oxidase Inhibitors) | Antidepressant agent |
| Contraindications: Epilepsy, liver disease, serious cardiovascular disease | MAOIs (Monoamine Oxidase Inhibitors) | Antidepressant agent |
| Contraindications: Must follow strict diet; Avoid food with tyramine; Provide pts a list of food or do not eat list | MAOIs (Monoamine Oxidase Inhibitors) | Antidepressant agent |
| Nardil (pheneizine) | MAOIs (Monoamine Oxidase Inhibitors) | Antidepressant agent |
| Parnate (tranylcypromine) | MAOIs (Monoamine Oxidase Inhibitors) | Antidepressant agent |
| Bipolar disorder; Lithium commonly used for treatment | Lithium (Eskalith) | Antipsychotic agent |
| Three types: Manic, Depressive, Mixed | Antipsychotic agent | |
| Does not produce sedation; Alters sodium transport; Used for prophylaxis and treatment | Lithium (Eskalith) | Antipsychotic agent |
| Interferes with nerve conduction | Lithium (Eskalith) | Antipsychotic agent |
| Contraindications: Renal disease, cardiovascular disease, severe dehydration, pregnancy, severe debilitation | Lithium (Eskalith) | Antipsychotic agent |
| Maybe extremely toxic, monitor levels monthly during maintenance and two or three times wkly during acute manic phase | Lithium (Eskalith) | Antipsychotic agent |
| Warning: Pts may have increase thirst and dehydration, lithium is a SALT - Adequate fluid intake is important | Lithium (Eskalith) | Antipsychotic agent |
| May be uses as sedative or hypnotic; Widely prescribe for anxiety | Benzodiazepine | Antianxiety agent |
Created by:
Ggoosey
Popular Pharmacology sets